Dr. Falk Pharma GmbH vs. Ellodi Pharmaceuticals LP

Explore the PTAB proceeding IPR2025-00056 filed by Dr. Falk Pharma GmbH on 2024-10-24. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00056

Filing Date

2024-10-24

Accorded Filing Date

2024-10-24

Institution Decision Date

2025-06-03

Last Modified Date

2026-03-31

Proceeding Type

IPR

Termination Date

2026-01-23

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Petitioner

Dr. Falk Pharma GmbH

Represented By

Luman, Nathanaelet al

Patent Owner / Respondent

Ellodi Pharmaceuticals LP

Represented By

Sukduang, Sanyaet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17211119

Respondent Patent Number 11260061

External Links

Espacenet

Google Patents

Respondent Inventor Michael A. GOSSELIN et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

121 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name COOLEY LLP - ATTN: IP Docketing Department

Customer Number 58249

Address 1299 Pennsylvania Avenue, NW, Suite 700, Washington, DC, 20004, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
33885	William Galliani	650-843-5622
34262	C Talbot	703-456-8072
36343	Matthew Langer	212-497-6000
40673	Heidi Keefe	650-843-5000
41087	Christopher Hutter	703-456-8506
42669	Brian Hopkins	617-937-2300
42764	Cynthia Kozakiewicz	617-937-2300
43210	Michael Tuscan	202-842-7802
43255	Bonnie Mcleod	202-842-7800
44047	Matthew Brigham	650-843-5000
44546	Kimberly Bolin	650-543-5000
44614	William Christiansen Ii	206-452-8700
45409	Heidi Erlacher	617-937-2325
45899	Christina Stock	617-937-2300
47777	Mika Mayer	650-843-5000
47938	William Shear	858-550-6000
48199	Lisa Amii	650-843-5000
48907	Dean Fanelli	202-776-2050
50572	Matthew Pavao	617-937-2300
51909	Carol Laherty	206-452-8700
52292	Connie Tong	650-843-5000
55854	Scott Weston	617-937-2327
56393	Daniel Knauss	317-582-0173
57835	Phillip Morton	703-456-8000
59129	Jeffery Wyzykowski	202-842-7800
59307	David Hopkins	720-566-4063
60024	Robert Wu	650-943-5000
61254	Alla Brukman	202-842-7800
61689	Margaret Fischofer	703-456-8000
62305	Jennifer Volk	703-456-8575
63322	Eamonn Gardner	858-550-6086
64349	Andrew Keith	202-842-7800
64497	Madhuri Roy	650-843-5000
64911	Mark Rogel	206-452-8700
65144	Samuel Whitt	202-776-2316
65421	Orion Armon	720-566-4119
66418	Jonathan Cousin	202-842-7800
67971	David Holly	202-842-7800
68766	Kenichi Hartman	650-843-5227
68774	Kassity Mai	202-452-8800
69078	Bethany Roahrig	720-466-4178
70120	Jeremy Binstock	703-456-8000
70211	Jason Valentine	202-728-7157
70786	Marcelo Pomeranz	858-550-6146
70897	Amy Motomura	310-883-6559
71499	Joanna Hubberts	650-843-5098
71583	Lesly Steinbeck	212-479-6561
72201	Michael Mcevoy	202-842-7800
72629	Anders Fernstrom	703-456-8117
73102	Michael Winternitz	202-728-7034
73162	Thomas Paxton	617-937-2473
73384	Chen Chen	617-937-2384
73445	Xiaomin Su	202-776-2295
73668	Aeraj Haque	312-881-6714
73724	Lawrence Teague	206-452-8700
73852	Jordan Phelan	202-728-7066
74178	Fraser Brown	202-842-7850
74347	Newman Han	202-728-7047
75031	Xiaozhen Yu	202-728-7127
75736	Xixi Sun	617-477-2458
76165	Fumin Shi	202-776-2064
76239	Dustin Knight	571-643-5164
76259	John Masters	312-881-6407
76373	Eric Owens	212-479-6656
76421	Meera Govindaraghavan	202-663-7410
76534	Mengke Mccullough	858-550-6118
76605	Matthew Scheideman	202-842-7858
76692	Asako Nagashima	202-728-7054
76824	Claudia Frehe	202-842-7800
76859	Nadeen Nsouli	312-881-6698
76906	Jessica Cande	617-937-2348
77360	Audrey Gallagher	312-881-6717
77479	Yin Nelson	202-776-2088
77606	Andrew Henderson	425-503-7202
77755	Scott Shaw	650-843-5000
77802	Robert Powers	617-937-2490
77848	Jordan Degayner	312-881-6392
77930	Mark Westwood	650-843-5005
78052	Alexia Dilg	202-842-7815
78279	Christine Dunne	617-937-2337
78292	Elizabeth Baez	703-727-4270
78433	David Schachter	212-479-6815
78664	Jill Kozumbo	202-962-8384
78703	Brendan Roach	202-776-2180
79013	Candace Britton	650-543-5000
79226	David Duron	650-843-5604
79280	Rachel Preston	202-776-2315
79296	Celeste Alvarez	858-550-6000
79442	Peter Chung	703-456-8587
79458	Sam Matthews	617-937-2388
79575	Felipe Guzman	617-937-2381
79769	Stephanie Johnson	631-943-0991
79828	Dou Yeon Youn	212-479-6381
80140	Philip Wdowiak	312-881-6697
80181	Natalie Hendrick	617-937-1387
80447	Claire Tourkin	650-843-5138
80682	Mengran Liu	650-843-5114
80739	Zhipeng Zheng	202-776-2043
80762	Taylor Canady	212-479-6000
80787	Jennifer Costigliola	919-491-1109
80800	Luke Sande	617-937-2367
81166	Nitasha Bennett	858-550-6480
81181	Georgia Calhoun	858-550-6181
81333	John Habibi	202-776-2137
81446	Ashley Sherrid	206-452-8824
81515	Nina Gu	617-937-1459
81534	Elif Ertem Bekdemir	617-937-2354
81599	Daniel Manson	212-479-6835
81740	Tian Yong Zheng	206-452-8774
81797	Rei Li	212-479-6084
81816	Michael Minsch Iv	212-479-6610
81920	Ying Yiu	206-452-8825
81992	Daniel Hinton	617-937-2403
82124	John Kozlowski	858-550-6056
82294	Kathleen Dinapoli	202-842-7800
82583	Maxwell Gonzalez	650-843-5434
82694	Austin Thind	703-456-8593
82984	Sarah Robbins	202-776-2034
83259	Ethan Decicco	617-937-2312
L1396	Shanxi Feng	202-776-2259
L1408	Gesa Junge	212-479-6658

Proceeding Documents

3101

Ex. 3101 Email correspondence Exhibit

2026-01-29 FILING PARTY: BOARD

Download

Adverse judgment: post-institution ADVRSJUDG

2026-01-23 FILING PARTY: BOARD

Download

2031

Disclaimer for U.S. Patent No. 11,260,061 Exhibit

2026-01-20 FILING PARTY: PATENT OWNER

Download

Patent Owner's Updated Exhibit List NOTICE

2026-01-20 FILING PARTY: PATENT OWNER

Download

Petitioner's Request for Oral Argument OTHER

2026-01-20 FILING PARTY: PETITIONER

Download

Dr. Falk Pharma GmbH vs. Ellodi Pharmaceuticals LP

Proceeding Overview

Parties & Counsel

Petitioner

Dr. Falk Pharma GmbH

Represented By

Patent Owner / Respondent

Ellodi Pharmaceuticals LP

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Ex. 3101 Email correspondence Exhibit

Adverse judgment: post-institution ADVRSJUDG

Disclaimer for U.S. Patent No. 11,260,061 Exhibit

Patent Owner's Updated Exhibit List NOTICE

Petitioner's Request for Oral Argument OTHER

Patent Owner's Motion to Terminate and Request for Adverse Judgment MOTION

Order: Authorizing Patent Owner’s Motion to Terminate ORDER

Ex. 3002 Attorney Correspondence Exhibit

November 3, 2025 Oral Hearing Transcript Regarding IPR2025-00052, IPR2025-00054, IPR2025-00055, and IPR2025-00056 Exhibit

Petitioner's Updated Exhibit List NOTICE

Petitioner's Supplemental Mandatory Notice: Related Matters Section NOTICE

General Order: Related Matters Updates ORDER

Patent Owner's Updated Mandatory Notices NOTICE

Patent Owner's Updated Exhibit List NOTICE

Agarwal Declaration Exhibit

Patent Owner's Notice of Intent to Designate I. Agarwal as Backup Counsel NOTICE

Joint Stipulation to Modify Due Dates 1-3 OTHER

Patent Owner's Notice of Deposition of Alan F. Parr, Pharm.D., Ph.D. NOTICE

Patent Owner's Objections Pursuant to 37 CFR 42.64(b)(1) OTHER

Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314 DECISION

Order: SCHEDULING ORDER ORDER

Patent Owner's SurReply OTHER

Petitioner’s Reply to Patent Owner’s Preliminary Response OTHER

E-mail authorizing briefing Exhibit

Curriculum vitae of Martyn Christopher Davies Exhibit

Merriam-Webster's Collegiate Dictionary, 11th ed. (2006) Exhibit

Declaration of Martyn Christopher Davies Exhibit

Patent Ower's Preliminary Response POPR

Petitioner’s Supplemental Mandatory Notice: Related Matters Section NOTICE

Notice: Notice filing date accorded NOTICE

Notice : Power of Attorney NOTICE

Notice : Mandatory Notice NOTICE

U.S. Publication No. 2009/0191275 to Dohil et al. (“Dohil2009”) Exhibit

“Cellulose, Silicified Microcrystalline,” Handbook of Pharmaceutical Exhibit

Siewert et al., “Eosinophilic gastroenteritis with severe protein-losing Exhibit

Notice of Publication of FDA Guidance for Industry on Orally Disintegrating Exhibit

Aceves et al., “Oral Viscous Budesonide: A potential new therapy for Exhibit

The Opposition Division of the European Patent Office decision regarding Exhibit

Konikoff et al., “A randomized, double-blind, placebo-controlled trial of f Exhibit

The United States Pharmacopeia, USP 32, 2009 at pages 262-263 “<701> Exhibit

U.S. Publication No. 2011/0081411 to Perrett et al. Exhibit

Curriculum Vitae of Alan F. Parr, Pharm.D., Ph.D. Exhibit

Remedios et al., “Eosinophilic esophagitis in adults: clinical, endoscopic Exhibit

Prosecution history excerpts from U.S. Application No. 14/917,125, which Exhibit

Budenofalk® Advertisement (2007) Exhibit

Declaration of Alan F. Parr, Pharm.D., Ph.D. regarding U.S. 11,260,061 Exhibit

U.S. Publication No. 20050232988 to Venkatesh et al. Exhibit

U.S. Patent No. 11,260,061 to Gosselin et al. Exhibit

Tan et al., “Eosinophilic gastroenteritis treated with non-enteric-coated b Exhibit

U.S. Publication No. 20070111978 to Dohil et al. (“Dohil”) Exhibit

Redline comparison of Dohil and Dohil2009 Exhibit

Budenofalk® Brochure (2005) Exhibit

EP3041476B1 Exhibit

Petition : as filed PETITION

Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 11th Exhibit

Danckwerts, “Intraoral Drug Delivery: A Comparative Review,” American Exhibit

Conway, “Solid dosage forms,” Chapter 4.1 in Pharmaceutical Manufacturing Exhibit

Kolkman et al., “Evaluation of oral budesonide in the treatment of active d Exhibit

Shukla et al., “Mouth Dissolving Tablets I: An overview of formulation tech Exhibit

International Publication No. WO2011041509 Exhibit

Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Exhibit

McGraw-Hill Dictionary of Scientific and Technical Terms, Sixth Edition Exhibit

Khan et al., “An approach for rapid disintegrating tablet: a review,” Int’l Exhibit

Roeder et al., “Safety and efficacy of fluticasone propionate in the Exhibit

Dr. Falk Pharma Brochure (2008) Exhibit